Bisphosphonate treatment as a cause of jaw osteonecrosis.
Kanat
O
O
Ozet
A
A
Ataergin
S
S
Kuzhan
O
O
Arpaci
F
F
Ozturk
B
B
Komurcu
S
S
Ozturk
M
M
D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D050071:Bone Density Conservation Agents / Q000009:adverse effects*; D004164:Diphosphonates / Q000009:adverse effects*; D006801:Humans; D007093:Imidazoles / Q000009:adverse effects; D007571:Jaw Diseases / Q000139:chemically induced* / Q000188:drug therapy; D010020:Osteonecrosis / Q000139:chemically induced* / Q000188:drug therapy; D014081:Tooth Extraction / Q000009:adverse effects; D000077211:Zoledronic Acid
D000900:Anti-Bacterial Agents; D050071:Bone Density Conservation Agents; D004164:Diphosphonates; D007093:Imidazoles; D000077211:Zoledronic Acid